Theranostics

doi:10.1016/B978-0-323-37127-8.00012-1

Biomaterials Nanoarchitectonics

2016, Pages 197-215

https://doi.org/10.1016/B978-0-323-37127-8.00012-1 Get rights and content

Abstract

This chapter discusses the applications of various nanomaterials employed in two modalities, that is, therapy and imaging. The concept of theranostics is the combination of both therapeutics and diagnostics in one package for image-guided therapy and also for defining the treatment outcome at an early stage. A more detailed description about the different categories of nanomaterials such as carbon-, polymer-, and metallic-based nanoparticles with regard to their ability to perform the dual modalities is given. Current techniques used for therapy including photothermal therapy and imaging tools such as optical, magnetic resonance imaging, and ultrasound are also described with their respective principles. The basic approaches developed by researchers for these classes of therapies and imaging modalities are also discussed. Current developments in theranostics along with several examples of additional techniques, which hold promise for the future of medicine, are specifically emphasized.

References (0)

Cited by (26)

Unlocking the power of MXenes – Crafting a 2D nanoplatform for tomorrow: Synthesis, functionalization, stability, and biomedical applications
2024, Materials Today Communications
The rapid advancement of theranostic nanoplatforms has sparked interest in the development of diverse inorganic nanocarriers with multifunctional properties for biomedical applications. MXenes are new inorganic nanomaterials with unique compositional, structural, and physicochemical characteristics. MXenes have been broadly used in diverse applications ranging from chemical, optical, electronic, and mechanical to biomedical fields. MXenes have excellent prospects for biological applications due to their large surface area and desirable near-infrared (NIR) absorption. Surface functionalization of MXenes with appropriate functionalization agents improves in vivo efficiency, minimises toxicity, increases circulation time, and improves colloidal stability. This review outlines the recent development of MXenes in biomedicines, surface modification techniques, synthesis strategies, and conjugation chemistry. It focuses on the major biomedical applications of MXenes, such as photothermal, theranostic, biosensing, and antibacterial activities. The last section of the article discusses the biosafety and stability characteristics of MXenes, along with addressing the challenges related to surface modification and clinical translation of 2D MXenes for biomedical applications. If the existing essential difficulties and obstacles are effectively addressed, 2D MXene-based nanosystems are predicted to have extensive applications in the theranostics of biomedicine.
Prospectives and retrospectives of microfluidics devices and lab-on-A-chip emphasis on cancer
2024, Clinica Chimica Acta
Microfluidics is a science and technology that deals with the concept of “less sample-to-more precision” enabling portable device development via fabrication for in vitro analysis. On evolution, microfluidic system lead to the development of Organ-on-chip where recapitulation of organ’s functionality and pathophysiological response can be performed under controlled environment. Further microfluidic-based “Lab–on–chip” device, a versatile innovation credited for its number of parameters that has capability to leverage next-generation companion of medicines. This emulsion science has enormous practise in the field of regenerative medicine, drug screening, medical diagnosis and therapy for accuracy in results. In this era of personalized medicine, getting precise tools for applying these theranostics is crucial. Oncological theranostics create a new gateway to develop precision in personalized medicine for cancer, where microfluidic chips are involved in diagnosis and therapy of various cancers using biomarkers for thyroid, lung cancers, and assay based for breast, circulating tumor cells and colorectal cancers and nanoparticles for ovarian cancer. This review shows more comprehensive approach to the state of art with respect to microfluidic devices in cancer theranostics.
Recent progress in the graphene-based biosensing approaches for the detection of Alzheimer's biomarkers
2023, Journal of Pharmaceutical and Biomedical Analysis
Citation Excerpt :
In this process, first, graphite is converted to graphite oxide by forming hydroxyl or carboxyl groups, covalently bound to a graphite planar carbon network. Then, the compound treats with strong oxidizers such as potassium chlorate and fuming nitric acid, and finally, exposing the oxidized materials to water gives conventional GO [41]. In comparison with graphite, the surface of GO was functionalized with oxygen-based groups contains hydroxyl (-OH), carbonyl (CO), epoxide, carboxylic acid (-COOH) and other oxygenated groups [29,42].
Alzheimer’s disease (AD) is one of the most common types of neurodegenerative disorders. It is possible to identify AD early thanks to the measurement of specific biomarker levels. Owing to crucial roles of biomarkers in the AD, the detection of AD-related biomarkers may be suitable for predictive identification of AD. Biosensors is a novel tool that could be beneficial to appreciate recognition of several AD biomarkers as early as possible. Graphene and its derivatives containing graphene oxide (GO) and reduced-GO (rGO) can be good choice for biosensing approaches due to their unique properties. GO/rGO-based biosensors or nanosensors have been widely used for the determination of AD biomarkers. In this article, the general aspects of AD, its biomarkers, biosensors, and GO are overviewed. In addition, this review provides the current developments in the applications of graphene-based biosensors for recognition of AD biomarkers. Future perspectives and challenges of graphene-based biosensing as a new approach for detection of AD are discussed in brief as well.
Biomarkers of oxidative stress and reproductive complications
2023, Advances in Clinical Chemistry
Oxidative stress is the result of an imbalance between the formation of reactive oxygen species (ROS) and the levels of enzymatic and non-enzymatic antioxidants. The assessment of biological redox status is performed by the use of oxidative stress biomarkers. An oxidative stress biomarker is defined as any physical structure or process or chemical compound that can be assessed in a living being (in vivo) or in solid or fluid parts thereof (in vitro), the determination of which is a reproducible and reliable indicator of oxidative stress. The use of oxidative stress biomarkers allows early identification of the risk of developing diseases associated with this process and also opens up possibilities for new treatments. At the end of the last century, interest in oxidative stress biomarkers began to grow, due to evidence of the association between the generation of free radicals and various pathologies. Up to now, a significant number of studies have been carried out to identify and apply different oxidative stress biomarkers in clinical practice. Among the most important oxidative stress biomarkers, it can be mentioned the products of oxidative modifications of lipids, proteins, nucleic acids, and uric acid as well as the measurement of the total antioxidant capacity of fluids in the human body. In this review, we aim to present recent advances and current knowledge on the main biomarkers of oxidative stress, including the discovery of new biomarkers, with emphasis on the various reproductive complications associated with variations in oxidative stress levels.
Synthesis of a theranostic platform based on fibrous silica nanoparticles for the enhanced treatment of triple-negative breast cancer promoted by a combination of chemotherapeutic agents
2022, Biomaterials Advances
Citation Excerpt :
Due to its tremendous potential, this multifunctional therapeutic approach has gained momentum within the medical community as underlined very recently in the cited reports [43,44]. Due to their special characteristics, nanomaterials offer a plethora of possibilities for cancer theranosis [37,45]. Within all the possibilities, nanomaterials of silica have been largely employed in biomedicine [41,46–52] for different purposes such as imaging (fluorescence and magnetic resonance imaging) [53], therapeutic controlled release of drugs [54–60] or imaging and therapy, as in the case of theranostics [20,48,61–65].
A new series of theranostic silica materials based on fibrous silica particles acting as nanocarriers of two different cytotoxic agents, namely, chlorambucil and an organotin metallodrug have been prepared and structurally characterized. Besides the combined therapeutic activity, these platforms have been decorated with a targeting molecule (folic acid, to selectively target triple negative breast cancer) and a molecular imaging agent (Alexa Fluor 647, to enable their tracking both in vitro and in vivo). The in vitro behaviour of the multifunctional silica systems showed a synergistic activity of the two chemotherapeutic agents in the form of an enhanced cytotoxicity against MDA-MB-231 cells (triple negative breast cancer) as well as by a higher cell migration inhibition. Subsequently, the in vivo applicability of the siliceous nanotheranostics was successfully assessed by observing with in vivo optical imaging techniques a selective tumour accumulation (targeting ability), a marked inhibition of tumour growth paired to a marked antiangiogenic ability after 13 days of systemic administration, thus, confirming the enhanced theranostic activity. The systemic nanotoxicity was also evaluated by analyzing specific biochemical markers. The results showed a positive effect in form of reduced cytotoxicity when both chemotherapeutics are administered in combination thanks to the fibrous silica nanoparticles. Overall, our results confirm the promising applicability of these novel silica-based nanoplatforms as advanced drug-delivery systems for the synergistic theranosis of triple negative breast cancer.
Sustainable membranes with FNMs for biomedical applications
2022, Membranes with Functionalized Nanomaterials: Current and Emerging Research Trends in Membrane Technology
In the recent era, membrane technology has grasped the attention of various researchers due to its diversified applications. Such a notable footstep of membrane technology in several processes increases widespread investigation on membrane science and, thereafter, its implementation toward value-added process outcome. One of the promising application areas of membrane science nowadays is its strong correlation with different biomedical processes. Pharmacokinetics, tissue engineering, wearable biohybrid organs, diagnostic devices, and hematology are some of the noteworthy segments, where membrane science has established itself as a ubiquitous technology to implement. However, the most intricacies that are aligning with the membrane separation techniques is its selectivity for the components to be separated, which is primarily manifested by the property of the casting material. In recent era, such properties of these fabricated membranes are modulated through numerous doping technologies during the casting process. One of the much-appreciated processes is doping of functionalized nanomaterials (FNMs), after pyrolitic production of nanomaterials from simulated waste followed by its functionalization, within the primitive membranes’ fabricating material during casting to aid different biomedical applications. Large effective surface area, biocompatibility, antibiofouling behavior, tunable pore structure as well as tunable pore modification and other distinctive chemical properties of the nanomaterials manifest an indigenous mechanism to regulate the property of the primitive substrate material when amalgamated. Thus, properties such as hydrophilicity/hydrophobicity, pore size, morphology, selectivity, glass transition temperature, elasticity, etc., can be controlled according to the application specificity of the membrane. Few research studies have revealed that membrane surface hydrophilicity was not directly relevant to the interfacial interaction with nanomaterials. Furthermore, the strength of electrostatic double-layer interaction may significantly increase with the increase of membrane surface zeta potential. However, the intrinsic properties of the nanomaterials depend on their fabrication technology, which is thoroughly discussed in this chapter. Moreover, the present chapter starts with a general discussion on nanomaterials and membranes, necessary to understand the basic interposed chemistry required for the preparation of FNM-doped membrane for different biomedical purposes. As said before, fabrication of FNMs and the doping methods are the most ubiquitous techniques to understand, which actually decides the final efficiency along with the specificity of the membrane technology. Hence, a substantial portion has been devoted to the fabrication science for FNMs and doping methods. Finally, the chapter concludes with some case studies elaborating adopted FNMs doped membrane technology for biomedical applications and how much such FNMs-based technology supersede conventional membrane science.

View all citing articles on Scopus

View full text

4.4 - Theranostics

Abstract